Literature DB >> 28755182

Molecular Aspects of the FAH Mutations Involved in HT1 Disease.

Geneviève Morrow1, Francesca Angileri1, Robert M Tanguay2.   

Abstract

Hereditary tyrosinemia type 1 (HT1) is caused by the lack of fumarylacetoacetate hydrolase (FAH), the last enzyme of the tyrosine catabolic pathway. Up to now, around 100 mutations in the FAH gene have been associated with HT1, and despite many efforts, no clear correlation between genotype and clinical phenotype has been reported. At first, it seems that any mutation in the gene results in HT1. However, placing these mutations in their molecular context allows a better understanding of their possible effects. This chapter presents a closer look at the FAH gene and its corresponding protein in addition to provide a complete record of all the reported mutations causing HT1.

Entities:  

Keywords:  Fumarylacetoacetate hydrolase (FAH); Hereditary tyrosinemia type 1 (HT1); Mutations

Mesh:

Substances:

Year:  2017        PMID: 28755182     DOI: 10.1007/978-3-319-55780-9_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Evaluation of dynamic thiol/disulfide homeostasis in hereditary tyrosinemia type 1 patients.

Authors:  Ayse Cigdem Aktuglu Zeybek; Ertugrul Kiykim; Salim Neselioglu; Halise Zeynep Iscan; Tanyel Zubarioglu; Mehmet Serif Cansever; Ozcan Erel
Journal:  Pediatr Res       Date:  2021-10-09       Impact factor: 3.953

2.  Amelioration of an Inherited Metabolic Liver Disease through Creation of a De Novo Start Codon by Cytidine Base Editing.

Authors:  Lei Yang; Liren Wang; Yanan Huo; Xi Chen; Shuming Yin; Yaqiang Hu; Xiaohui Zhang; Rui Zheng; Hongquan Geng; Honghui Han; Xueyun Ma; Meizhen Liu; Haibo Li; Weishi Yu; Mingyao Liu; Jun Wang; Dali Li
Journal:  Mol Ther       Date:  2020-05-07       Impact factor: 11.454

3.  Treatment adherence in tyrosinemia type 1 patients.

Authors:  Domingo González-Lamuño; Paula Sánchez-Pintos; Fernando Andrade; María L Couce; Luís Aldámiz-Echevarría
Journal:  Orphanet J Rare Dis       Date:  2021-06-03       Impact factor: 4.123

4.  Hereditary tyrosinemia type I-associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate.

Authors:  Iratxe Macias; Ana Laín; Ganeko Bernardo-Seisdedos; David Gil; Esperanza Gonzalez; Juan M Falcon-Perez; Oscar Millet
Journal:  J Biol Chem       Date:  2019-07-12       Impact factor: 5.157

5.  Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant.

Authors:  Isabel Ibarra-González; Cynthia Fernández-Lainez; Miguel Angel Alcántara-Ortigoza; Ariadna González-Del Angel; Liliana Fernández-Henández; Sara Guillén-López; Leticia Belmont-Martínez; Lizbeth López-Mejía; Gustavo Varela-Fascinetto; Marcela Vela-Amieva
Journal:  Mol Genet Genomic Med       Date:  2019-09-30       Impact factor: 2.183

6.  Multiplex precise base editing in cynomolgus monkeys.

Authors:  Wenhui Zhang; Tomomi Aida; Ricardo C H Del Rosario; Jonathan J Wilde; Chenhui Ding; Xiaohui Zhang; Zulqurain Baloch; Yan Huang; Yu Tang; Duanduan Li; Hongyu Lu; Yang Zhou; Minqing Jiang; Dongdong Xu; Zhihao Fang; Zhanhong Zheng; Qunshan Huang; Guoping Feng; Shihua Yang
Journal:  Nat Commun       Date:  2020-05-11       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.